AFL Stock Analysis — Aflac
Sector: Financials
AI Verdict
Aflac trades at 17.4x next year's earnings despite analysts forecasting a -25.3% drop, so you're paying a premium the numbers don't yet support unless its distribution moat can deliver a surprise rebound.
Competitive Moat
Aflac dominates the supplemental health and life insurance niche in Japan and the US, leveraging long-term distribution partnerships with employers and banks that are hard for new entrants to replicate. Its brand recognition and entrenched agent network create high switching costs for policyholders.
Summary
Aflac's forward P/E has jumped to 17.4x as analysts expect a sharp -25.3% drop in earnings next year.
Where It Stands
Aflac returned 15.00% over the past year, but its RSI of 36.3 signals the stock is cooling off after that run, while a forward P/E of 17.4x is above the sector median of 14x despite negative earnings expectations.
Key Metrics
- RSI: 36.3 — Near Oversold
- Trailing P/E: 13.0x
- Forward P/E: 17.4x
- Earnings Growth: -0.3%
- Revenue Growth: +0.1%
- Market Cap: $60.7B
- Dividend Yield: 0.02%
- 1-Year Return: 15.00%
- 52-Week High: $130.22
- 52-Week Low: $103.51
Analyst Consensus
3 Buy · 12 Hold · 8 Sell (23 analysts)
Bull Case
A trailing P/E of 13.0x means you're still paying below the sector median for the last year's earnings, with a 7.2% revenue growth showing some underlying business momentum.
Bear Case
If the forward P/E of 17.4x compresses back to the sector median of 14x as earnings fall, the stock could see a 20% valuation drop even before factoring in the -25.3% EPS decline.
Catalyst to Watch
Watch for quarterly earnings updates—if management can stabilize or reverse the expected -25.3% EPS decline, the premium multiple may hold.